PMID: 6409238Jul 16, 1983Paper

Improved tumour localisation using indium-111 labelled antibodies

British Medical Journal
D S FairweatherS Chandler

Abstract

Immunoglobulin G (IgG) antibodies to carcinoembryonic antigen (CEA) were labelled with radioactive indium (111In) or iodine (131I) and a comparison made of their value in locating CEA producing tumours. Eleven patients given 111In-anti-CEA had 31 tumours as judged by a combination of all techniques. Of these, 28 were detected by 111In-anti-CEA and 26 by conventional clinical techniques. Five of the patients also received 131I-anti-CEA. These patients had 15 tumour areas. Thirteen were detected by 111In and eight by 131I. 111In also produced a better signal to noise ratio in the scans and thereby showed lesions with greater certainty. In addition, the 111In isotope continued to accumulate in the tumour areas for considerably longer than 131I. Absorbed doses (whole body) were similar for both isotopes. The results show that antibody scanning is greatly improved by using 111In as the radiolabel in place of 131I and should allow the detection of smaller or deeper lesions.

References

May 1, 1979·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·S J Wagner, M J Welch
Jul 25, 1977·Biochemical and Biophysical Research Communications·G E Krejcarek, K L Tucker
Dec 1, 1974·Journal of Medicinal Chemistry·M W SundbergC I Diamanti
Mar 1, 1972·Immunochemistry·M L EganC W Todd
Sep 18, 1982·Lancet·D S FairweatherP W Dykes
Dec 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·D M GoldenbergF H DeLand
Jun 1, 1983·Clinical Endocrinology·D S FairweatherR Hoffenberg

❮ Previous
Next ❯

Citations

Jan 1, 1987·Journal of Cancer Research and Clinical Oncology·D M Goldenberg
Jan 1, 1985·European Journal of Nuclear Medicine·P C JacksonC A Sunderland
Jun 12, 1990·Journal of Immunological Methods·E M MorrelM L Yarmush
Nov 1, 1993·Pharmacology & Therapeutics·G WeckbeckerC Bruns
Mar 1, 1985·European Journal of Cancer & Clinical Oncology·A M Neville, B A Gusterson
Jan 1, 1987·Baillière's Clinical Gastroenterology·C B Wilson, A A Epenetos
Jan 5, 1991·BMJ : British Medical Journal·J Hollingworth
Sep 1, 1987·The British Journal of Radiology·S T Chandler, P Anderson
Jun 1, 1987·The British Journal of Radiology·A T VaughanA R Bradwell
Sep 11, 1991·World Journal of Surgery·M K Lange, E W Martin
Jun 1, 1987·Cancer Treatment Reviews·P W DykesA T Vaughan
Jan 1, 1988·International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology·P AndersonN R Varley
Jun 1, 1987·European Journal of Cancer & Clinical Oncology·D TaitR J Ott
Dec 1, 1994·Scandinavian Journal of Clinical and Laboratory Investigation·K J Kairemo, K Liewendahl
Mar 1, 1992·Bioconjugate Chemistry·K D Brandt, D K Johnson
Jan 1, 1990·International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology·Y NarukiS M Larson
Jan 1, 1991·International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology·J F MorrisG T Krishnamurthy
Jan 1, 1986·International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology·M C WardR J Ott
Jan 23, 1984·FEBS Letters·R G Buckley, F Searle
Dec 1, 1984·The British Journal of Surgery·P G ReasbeckB B Berkeley
May 1, 1990·Clinical Physiology·K E Britton
Jun 15, 1990·International Journal of Cancer. Journal International Du Cancer·G PaganelliA A Epenetos
Oct 1, 1989·Seminars in Nuclear Medicine·D M GoldenbergH J Hansen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.